Annual long term liabilities:
$41.55M+$1.45M(+3.62%)Summary
- As of today (September 17, 2025), AVDL annual total long term liabilities is $41.55 million, with the most recent change of +$1.45 million (+3.62%) on December 31, 2024.
- During the last 3 years, AVDL annual long term liabilities has fallen by -$106.47 million (-71.93%).
- AVDL annual long term liabilities is now -72.14% below its all-time high of $149.14 million, reached on December 31, 2018.
Performance
AVDL Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$39.38M-$3.56M(-8.30%)Summary
- As of today (September 17, 2025), AVDL quarterly total long term liabilities is $39.38 million, with the most recent change of -$3.56 million (-8.30%) on June 1, 2025.
- Over the past year, AVDL quarterly long term liabilities has dropped by -$3.24 million (-7.60%).
- AVDL quarterly long term liabilities is now -77.83% below its all-time high of $177.62 million, reached on March 31, 2018.
Performance
AVDL quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AVDL Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.6% | -7.6% |
| 3 y3 years | -71.9% | -65.8% |
| 5 y5 years | -71.3% | -70.2% |
AVDL Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.9% | +3.6% | -66.3% | +526.9% |
| 5 y | 5-year | -71.9% | +3.6% | -73.4% | +526.9% |
| alltime | all time | -72.1% | +1977.7% | -77.8% | +2087.9% |
AVDL Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $39.38M(-8.3%) |
| Mar 2025 | - | $42.95M(-59.8%) |
| Dec 2024 | $41.55M(+3.6%) | $106.75M(+161.6%) |
| Sep 2024 | - | $40.81M(-4.3%) |
| Jun 2024 | - | $42.62M(+2.2%) |
| Mar 2024 | - | $41.71M(-59.1%) |
| Dec 2023 | $40.10M(-59.1%) | $102.08M(+162.4%) |
| Sep 2023 | - | $38.90M(+519.2%) |
| Jun 2023 | - | $6.28M(-93.7%) |
| Mar 2023 | - | $99.54M(+29.1%) |
| Dec 2022 | $98.14M(-33.7%) | $77.08M(-33.9%) |
| Sep 2022 | - | $116.69M(+1.4%) |
| Jun 2022 | - | $115.05M(-5.6%) |
| Mar 2022 | - | $121.87M(-17.7%) |
| Dec 2021 | $148.02M(+10.2%) | $148.02M(+0.3%) |
| Sep 2021 | - | $147.54M(+0.1%) |
| Jun 2021 | - | $147.43M(+0.1%) |
| Mar 2021 | - | $147.32M(+9.7%) |
| Dec 2020 | $134.26M(-7.2%) | $134.26M(+0.6%) |
| Sep 2020 | - | $133.43M(+0.9%) |
| Jun 2020 | - | $132.26M(-7.7%) |
| Mar 2020 | - | $143.32M(-0.9%) |
| Dec 2019 | $144.65M(-3.0%) | $144.65M(-4.3%) |
| Sep 2019 | - | $151.09M(+0.8%) |
| Jun 2019 | - | $149.91M(-1.3%) |
| Mar 2019 | - | $151.85M(+1.8%) |
| Dec 2018 | $149.14M(+83.8%) | $149.14M(-4.5%) |
| Sep 2018 | - | $156.25M(-5.4%) |
| Jun 2018 | - | $165.08M(-7.1%) |
| Mar 2018 | - | $177.62M(+118.9%) |
| Dec 2017 | $81.16M(-42.4%) | $81.16M(-3.0%) |
| Sep 2017 | - | $83.66M(-10.7%) |
| Jun 2017 | - | $93.72M(-18.9%) |
| Mar 2017 | - | $115.56M(-18.0%) |
| Dec 2016 | $140.99M(+40.0%) | $140.99M(-7.2%) |
| Sep 2016 | - | $151.97M(+8.8%) |
| Jun 2016 | - | $139.68M(+2306.6%) |
| Mar 2016 | - | $5.80M(-94.3%) |
| Dec 2015 | $100.70M(+28.3%) | $101.94M(+1157.6%) |
| Mar 2015 | - | $8.11M(-89.9%) |
| Dec 2014 | $78.47M(-7.9%) | $80.34M(+4.9%) |
| Sep 2014 | - | $76.62M(-2.9%) |
| Jun 2014 | - | $78.93M(+19.0%) |
| Mar 2014 | - | $66.32M(+103.7%) |
| Dec 2013 | $85.17M(+17.6%) | $32.56M(-0.7%) |
| Sep 2013 | - | $32.79M(-1.4%) |
| Jun 2013 | - | $33.26M(-9.2%) |
| Mar 2013 | - | $36.61M(-6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $72.45M(+240.2%) | $38.99M(-11.5%) |
| Jun 2012 | - | $44.06M(-52.8%) |
| Mar 2012 | - | $93.35M(+309.5%) |
| Dec 2011 | $21.29M(+12.7%) | $22.80M(+0.5%) |
| Sep 2011 | - | $22.69M(-10.3%) |
| Jun 2011 | - | $25.31M(+44.6%) |
| Mar 2011 | - | $17.50M(-7.3%) |
| Dec 2010 | $18.89M(-28.8%) | $18.89M(-3.4%) |
| Sep 2010 | - | $19.55M(-0.4%) |
| Jun 2010 | - | $19.64M(-10.1%) |
| Mar 2010 | - | $21.85M(-17.7%) |
| Dec 2009 | $26.54M(+15.1%) | $26.54M(+0.6%) |
| Sep 2009 | - | $26.37M(-2.7%) |
| Jun 2009 | - | $27.10M(+19.5%) |
| Mar 2009 | - | $22.68M(-1.7%) |
| Dec 2008 | $23.06M(+5.7%) | $23.06M(+17.9%) |
| Sep 2008 | - | $19.56M(-10.8%) |
| Jun 2008 | - | $21.93M(-1.5%) |
| Mar 2008 | - | $22.26M(+2.0%) |
| Dec 2007 | $21.82M(+6.2%) | $21.82M(+1.7%) |
| Sep 2007 | - | $21.45M(-4.3%) |
| Jun 2007 | - | $22.43M(+8.3%) |
| Mar 2007 | - | $20.70M(+0.7%) |
| Dec 2006 | $20.55M(+60.6%) | $20.55M(+6.3%) |
| Sep 2006 | - | $19.33M(+28.8%) |
| Jun 2006 | - | $15.01M(+11.5%) |
| Mar 2006 | - | $13.46M(+5.1%) |
| Dec 2005 | $12.80M(+131.7%) | $12.80M(+7.9%) |
| Sep 2005 | - | $11.87M(+69.8%) |
| Jun 2005 | - | $6.99M(+26.0%) |
| Mar 2005 | - | $5.55M(+0.4%) |
| Dec 2004 | $5.53M(-68.1%) | $5.53M(-55.7%) |
| Sep 2004 | - | $12.48M(0.0%) |
| Jun 2004 | - | $12.48M(-12.2%) |
| Mar 2004 | - | $14.21M(-18.0%) |
| Dec 2003 | $17.32M(+304.6%) | $17.32M(+270.5%) |
| Sep 2003 | - | $4.67M(-13.7%) |
| Jun 2003 | - | $5.42M(+1.3%) |
| Mar 2003 | - | $5.35M(+25.0%) |
| Dec 2002 | $4.28M(+2.6%) | $4.28M(+1.8%) |
| Sep 2002 | - | $4.21M(+0.8%) |
| Dec 2001 | $4.17M(+24.0%) | $4.17M(+24.0%) |
| Dec 2000 | $3.37M(+42.7%) | $3.37M(+42.7%) |
| Dec 1999 | $2.36M(-25.8%) | $2.36M(-25.8%) |
| Dec 1998 | $3.18M(+2.6%) | $3.18M(+6.0%) |
| Mar 1998 | - | $3.00M(-3.2%) |
| Dec 1997 | $3.10M(+55.0%) | $3.10M(+55.0%) |
| Dec 1996 | $2.00M | $2.00M(+11.1%) |
| Mar 1996 | - | $1.80M |
FAQ
- What is Avadel Pharmaceuticals plc annual total long term liabilities?
- What is the all time high annual long term liabilities for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual long term liabilities year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly long term liabilities year-on-year change?
What is Avadel Pharmaceuticals plc annual total long term liabilities?
The current annual long term liabilities of AVDL is $41.55M
What is the all time high annual long term liabilities for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual total long term liabilities is $149.14M
What is Avadel Pharmaceuticals plc annual long term liabilities year-on-year change?
Over the past year, AVDL annual total long term liabilities has changed by +$1.45M (+3.62%)
What is Avadel Pharmaceuticals plc quarterly total long term liabilities?
The current quarterly long term liabilities of AVDL is $39.38M
What is the all time high quarterly long term liabilities for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly total long term liabilities is $177.62M
What is Avadel Pharmaceuticals plc quarterly long term liabilities year-on-year change?
Over the past year, AVDL quarterly total long term liabilities has changed by -$3.24M (-7.60%)